InMed Pharmaceuticals Inc.
INM—
$0.00
+$0.00(+NaN%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
—
P/E ratio
—
EPS (diluted)
$-8.36
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
$4.94M
Net income
$-8.16M
Net margin
-165.1%
Gross margin
34.5%
Dividends & financials
InMed Pharmaceuticals Inc. (INM) reported revenue of $4.94M and net income of $-8.16M, or $-8.36 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.
